Abiopharma

(99% Neutral) UROGEN PHARMA LTD. (URGN) Announces Business Combination

Pfizer Inc. - Pfizer Analyst and Investor Call to Review RSV Data Presented at ID Week 2022

(10% Negative) SILVERBACK THERAPEUTICS, INC. (SBTX) Announces Delay in anaphylaxis Trials for review ARS Pharmaceuticals Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Mereo BioPharma (MREO) Announces 2022 Annual General Meeting

(99% Neutral) Aurinia Pharmaceuticals Inc. (AUPH) Announces Executive Departure

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Ironwood - Ironwood Pharmaceuticals Q3 2022 Investor Update Conference Call

Cytokinetics to Announce Third Quarter Results on November 3, 2022

(10% Negative) ChemoCentryx, Inc. (CCXI) Announces Delay in difference Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review

(10% Negative) AMGEN INC (AMGN) Announces Delay in difference Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review